STEPHANIE CHOATE: Open Payments
NPI 1720570609 · SALLISAW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,509 in 90 payments from 17 companies in 2025. Trend: 2023 $203 · 2024 $1,618 · 2025 $1,509
Food & beverage: $1,509
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $276 |
| ABBVIE INC. | 20 | $208 |
| Dexcom, Inc. | 1 | $164 |
| Otsuka America Pharmaceutical, Inc. | 10 | $155 |
| AstraZeneca Pharmaceuticals LP | 7 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $115 |
| Lilly USA, LLC | 7 | $111 |
| PFIZER INC. | 4 | $77 |
| Viatris Specialty LLC | 4 | $66 |
| Axsome Therapeutics, Inc. | 3 | $53 |
Products named: VRAYLAR, Wegovy, Dexcom G6 Transmitter, REXULTI, AIRSUPRA, Kerendia, Ozempic, YUPELRI.
Industry payments across OK — which companies pay providers there.
